Avanos Medical, Inc. (AVNS) Earnings History
Annual and quarterly earnings data from 2012 to 2025
Loading earnings history...
AVNS EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
AVNS Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 49.8% | -8.8% | -9.7% |
| 2024 | 55.4% | 5.8% | -57.0% |
| 2023 | 56.4% | 9.7% | -9.2% |
| 2022 | 57.6% | 6.1% | 7.4% |
| 2021 | 51.0% | 11.7% | 0.8% |
Download Data
Export AVNS earnings history in CSV or JSON format
Free sign-in required to download data
Avanos Medical, Inc. (AVNS) Earnings Overview
As of May 6, 2026, Avanos Medical, Inc. (AVNS) reported trailing twelve-month net income of -$69M, reflecting +82.9% year-over-year growth. The company earned $-1.50 per diluted share over the past four quarters, with a net profit margin of -9.7%.
Looking at the long-term picture, AVNS's historical earnings data spans multiple years. The company achieved its highest annual net income of $155M in fiscal 2013.
Avanos Medical, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including MMSI ($139M net income, 8.5% margin), NVCR (-$173M net income, -20.8% margin), ITGR ($142M net income, 5.6% margin), AVNS has room to improve margins relative to the peer group. Compare AVNS vs MMSI →
AVNS Earnings vs Peers
Earnings metrics vs comparable public companies
AVNS Historical Earnings Data (2012–2025)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$68M | +82.7% | -$62M | $-1.46 | -9.7% | -8.8% |
| 2024 | -$392M | -534.5% | $40M | $-8.53 | -57.0% | 5.8% |
| 2023 | -$62M | -222.4% | $65M | $-1.33 | -9.2% | 9.7% |
| 2022 | $51M | +701.6% | $42M | $1.07 | 7.4% | 6.1% |
| 2021 | $6M | +123.2% | $87M | $0.13 | 0.8% | 11.7% |
| 2020 | -$27M | +40.7% | $71M | $-0.57 | -3.8% | 9.9% |
| 2019 | -$46M | -179.8% | -$5M | $-0.96 | -6.6% | -0.8% |
| 2018 | $58M | -27.5% | $35M | $1.22 | 8.8% | 5.4% |
| 2017 | $79M | +99.2% | -$16M | $1.69 | 13.0% | -2.6% |
| 2016 | $40M | +109.3% | -$69M | $0.85 | 7.0% | -12.3% |
See AVNS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AVNS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AVNS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAVNS — Frequently Asked Questions
Quick answers to the most common questions about buying AVNS stock.
Is AVNS growing earnings?
AVNS EPS is $-1.50, with earnings growth accelerating to +82.9%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-69M.
What are AVNS's profit margins?
Avanos Medical, Inc. net margin is -9.7%, with operating margin at -8.8%. Below-average margins reflect competitive or cost pressures.
How consistent are AVNS's earnings?
AVNS earnings data spans 2012-2025. The accelerating earnings trend is +82.9% YoY. Historical data enables comparison across business cycles.